Hemodialysis Vascular Grafts Market Size, Share & Trends Report

Hemodialysis Vascular Grafts Market Size, Share & Trends Analysis Report By Raw Material (Polyester, Polytetrafluoroethylene, Polyurethane, Biological Materials), And Segment Forecasts, 2019 - 2025

  • Published Date: Jan, 2019
  • Base Year for Estimate: 2017
  • Report ID: GVR-2-68038-731-5
  • Format: Electronic (PDF)
  • Historical Data: 2014 - 2016
  • Number of Pages: 77

Industry Insights

The global hemodialysis vascular grafts market size was valued at USD 209.1 million in 2018. It is likely to expand at a CAGR of 4.1 % over the forecast period. Increasing prevalence of renal disorders, growing adoption of biological access grafts, and technological advancements in these products are some of the factors expected to drive the market over the forecast period.

Limited availability of kidney donors is leading to an increase in the number of patients with chronic kidney disease (CKD) opting for hemodialysis. As a result, the demand for hemodialysis vascular grafts is projected to witness an upswing during the forecast period.

U.S. hemodialysis vascular grafts market

Developing economies have large unmet population suffering from CKD, due to delayed diagnosis, comparatively poor healthcare facilities, unavailability of suitable kidney donors, and presence of cost-sensitive patient pool. Hence, kidney transplantation procedure has less preference as compared to hemodialysis procedure in developing economies, owing to presence of cheaper alternatives such as vascular access grafts.

Increasing awareness about CKD in these countries is anticipated to boost the growth of the market over the forecast period. For instance, India Renal Foundation is a non-governmental organization involved in conducting awareness programs for prevention of kidney diseases and have conducted about 15,000 programs till date.

Patients undergoing dialysis must get long-term central venous catheterization, while they also have alternate option of arteriovenous graft (AVG). This AVG is used in case, where all superficial veins of patients are exhausted due to continuous process of hemodialysis. Although synthetic polytetrafluoroethylene (PTFE) grafts are becoming popular worldwide, they have several disadvantages such as steal syndrome, high risk of infection, and long patency. As compared to synthetic, biological access grafts have higher patient benefits such as lower risk of infection and fewer chances of rejections.

Raw Material Insights

On the basis of raw material, the market has been segmented into polyester, polytetrafluoroethylene, polyurethane, and biological materials. The polytetrafluoroethylene segment dominated the market and accounted for 45.0% of the overall revenue in 2018. The growth of the segment can be attributed to factors such as better adhesion and pliability as compared to other materials and similar patency as compared to other synthetic products.

Hemodialysis access products manufactured using single component polyester-polyurethane are hydrolytically unstable after implantation. C. R. Bard, Inc. developed Vectra for vascular access, which is composed of polyetherurethaneurea and siloxane that contains surface-modifying additive. This product shows rapid hemostasis, within 1 to 5 minutes of needle withdrawal. Launch of novel products is expected to contribute to the growth of the overall hemodialysis vascular grafts market.

Biological vascular access grafts are made by human saphenous veins and other tissue engineered materials. These grafts are preferred as compared to synthetic types due to less number of infections, higher patency, and higher durability as compared to other synthetic grafts. These grafts are ideal solutions that can be used for treating vascular graft infections and for patients who are at risk of AV access infections. The segment is likely to witness a CAGR of 3.3% during the forecast period.

Regional Insights

North America accounted for the highest revenue share in 2017 in the global arena. Higher healthcare expenditure as a percentage of GDP, higher preference for biological and tissue engineered vascular access grafts, and increased number of patients with CKD are among the primary growth stimulants for the regional market.

Global hemodialysis vascular grafts market

U.S. alone accounted for over 27.0% of the global market revenue in 2018. Higher number of CKD patients and growing penetration of synthetic hemodialysis vascular access grafts are supplementing the growth of the market. Europe represented approximately 24.0% of the total revenue in 2017, due to increased preference for hemodialysis as compared to peritoneal dialysis. Growing acceptance of these products for hemodialysis in this region is augmenting the regional market.

The Asia Pacific market is poised to witness the highest CAGR of 6.6% between 2018 and 2025, due to mounting cases of patients suffering from CKD, unavailability of suitable kidney donors, and increasing per capita healthcare expenditure. Rising number of dialysis procedures in the region is projected to create lucrative growth opportunities for the market in Asia Pacific over the forecast period.

Hemodialysis Vascular Grafts Market Share Insight

The market is oligopolistic and dominated by few companies such as W.L. Gore & Associates; C. R. Bard, Inc.; Terumo Medical Corporation; LeMaitre Vascular, Inc.; and Getinge AB. Other companies operating in the market are Vascular Genesis; InnAVasc Medical, Inc.; CryoLife, Inc.; Merit Medical Systems, Inc.; and Proteon Therapeutics, Inc. The competition in the market is anticipated to increase over the forecast period due to launch of new and technologically advanced cost-effective grafts.

Report Scope



Base year for estimation


Actual estimates/Historical data

2014 - 2016

Forecast period

2018 - 2025

Market representation

Revenue in USD Million and CAGR from 2018 to 2025

Regional scope

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

Country scope

U.S., Canada, U.K., Germany, China, Japan, Brazil, Mexico, South Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific information, which is not currently within the scope of the report, we will provide it to you as a part of customization

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global hemodialysis vascular grafts market report on the basis of raw material type and region:

  • Raw Material Outlook (Revenue, USD Million, 2014 - 2025)

    • Polyester

    • Polytetrafluoroethylene

    • Polyurethane

    • Biological Materials

  • Regional Outlook (Revenue, USD Million, 2014 - 2025)

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

    • Asia Pacific

      • Japan

      • China

    • Latin America

      • Brazil

      • Mexico

    • Middle East & Africa

      • South Africa

Pricing & Purchase Options

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert.

  • Custom research service

    Custom research service

    Design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • grand view research PCI DSS complaint grand view research paypal verified